{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:20:28Z","timestamp":1779366028227,"version":"3.53.0"},"reference-count":48,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The multidrug nature of anticancer treatment and different treatment protocols used in the studies are likely to be a major limitation in establishing real risk factors determining the occurrence of dental abnormalities. The authors aimed to establish a relationship between the duration and the dose of chemotherapy and the number of tooth adverse effects in the group receiving the same treatment. Of the 40 anticancer therapy recipients who attended the outpatient dental clinic, 7 leukemia survivors receiving the treatment according to the ALL IC-BFM 2002 protocol were selected. The study group consisted of four females and three males aged 92 to 207 months at the time of dental examination and 29 to 91 months at leukemia diagnosis. As a result of the clinical and radiological examination, dental abnormalities such as agenesis, tooth size reduction, root abnormalities, and taurodontia were identified, and the medical records of all survivors were reviewed in terms of drugs administered, their doses, and treatment schedules. No correlation was observed between the treatment duration of an intensive therapy, the entire therapy, and the number of tooth abnormalities. No relationship was also found between the number of dental abnormalities and the cumulative dose of vincristine, L-asparaginase, methotrexate, cyclophosphamide, cytarabine, and 6-mercaptopurine. The age at the onset of antineoplastic therapy is likely to be the strongest risk factor for toxic injury during tooth development.<\/jats:p>","DOI":"10.3390\/cancers15225420","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T10:57:46Z","timestamp":1700045866000},"page":"5420","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tooth Abnormalities and Their Age-Dependent Occurrence in Leukemia Survivors"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-1612","authenticated-orcid":false,"given":"Anna","family":"Jod\u0142owska","sequence":"first","affiliation":[{"name":"Department of Pediatric Dentistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6573-019X","authenticated-orcid":false,"given":"Lidia","family":"Postek-Stefa\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dentistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ped.13457","article-title":"Treatment and biology of pediatric acute lymphoblastic leukemia","volume":"60","author":"Kato","year":"2018","journal-title":"Pediatr. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0140-6736(14)62395-3","article-title":"Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms\u2019 tumour (SIOP WT 2001): An open-label, non-inferiority, randomised controlled trial","volume":"386","author":"Bergeron","year":"2015","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MPH.0000000000000206","article-title":"Mercaptopurine\/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: Clinical facts and fiction","volume":"36","author":"Schmiegelow","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4274\/tjh.galenos.2018.2018.0248","article-title":"Long-term dental anomalies after pediatric cancer treatment in children","volume":"36","author":"Bulut","year":"2019","journal-title":"Turk. J. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4143\/crt.2015.193","article-title":"Dental anomalies as late adverse effect among young children treated for cancer","volume":"48","author":"Proc","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/pbc.24842","article-title":"A systematic review of dental late effects in survivors of childhood cancer","volume":"61","author":"Gawade","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/pbc.22902","article-title":"Disturbed dental development of permanent teeth in children with solid tumors and lymphomas","volume":"58","author":"Cubukcu","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1601-6343.2006.00374.x","article-title":"Microdontia after chemotherapy in a child treated for neuroblastoma","volume":"9","author":"Remmers","year":"2006","journal-title":"Orthod. Craniofacial Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/cncr.20967","article-title":"Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT","volume":"103","author":"Hovi","year":"2005","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/cncr.20762","article-title":"Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children","volume":"103","author":"Alaluusua","year":"2005","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/08880010500198848","article-title":"Long-term effects of chemotherapy on dental status in children treated for nephroblastoma","volume":"22","author":"Lagrange","year":"2005","journal-title":"Pediatr. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0909-8836.2004.00094.x","article-title":"Long-term effects of chemotherapy on orodental structures in children with non-Hodgkin\u2019s lymphoma","volume":"112","author":"Oguz","year":"2004","journal-title":"Eur. J. Oral Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1096-911X(199801)30:1<22::AID-MPO8>3.0.CO;2-2","article-title":"Dental abnormalities in children treated for neuroblastoma","volume":"30","author":"Kaste","year":"1998","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/1097-0142(19870501)59:9<1640::AID-CNCR2820590920>3.0.CO;2-V","article-title":"Altered dental root development in long-term survivors of pediatric acute lymphoblastic leukemia","volume":"59","author":"Rosenberg","year":"1987","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.17219\/dmp\/138914","article-title":"Duration and dose of chemotherapy and dental development","volume":"59","year":"2022","journal-title":"Dent. Med. Probl."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jod\u0142owska, A., and Postek-Stefa\u0144ska, L. (2022). Systemic anticancer therapy details and dental adverse effects in children. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19116936"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00520-015-2940-1","article-title":"Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7\u201340 years after diagnosis","volume":"24","author":"Wilberg","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4143\/crt.2017.296","article-title":"Clinical risk factors influencing dental developmental disturbances in childhood cancer survivors","volume":"50","author":"Kang","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-263X.2011.01199.x","article-title":"Microdontia and hypodontia of premolars and permanent molars in childhood cancer survivors after chemotherapy","volume":"22","author":"Pedersen","year":"2012","journal-title":"Int. J. Paediatr. Dent."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.tripleo.2007.02.029","article-title":"Long-term effects of chemotherapy on caries formation, dental development and salivary factors in childhood cancer survivors","volume":"104","author":"Avsar","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0145-2126(02)00080-2","article-title":"Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia","volume":"27","author":"Minicucci","year":"2003","journal-title":"Leuk. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(19871115)60:10<2570::AID-CNCR2820601037>3.0.CO;2-Q","article-title":"The long-term effects of treatment on the dental condition of children surviving malignant disease","volume":"60","author":"Maguire","year":"1987","journal-title":"Cancer"},{"key":"ref_23","first-page":"394","article-title":"Antineoplastic chemotherapy and congenital tooth abnormalities in children and adolescents","volume":"20","year":"2016","journal-title":"Contemp. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4317\/medoral.17955","article-title":"Decayed, missing and filled teeth index and dental anomalies in long-term survivors leukaemic children: A prospective controlled study","volume":"17","author":"Lauritano","year":"2012","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/archdischild-2016-311251","article-title":"Clinical presentation of childhood leukaemia: A systematic review and meta-analysis","volume":"101","author":"Clarke","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"ref_26","first-page":"460","article-title":"Acute lymphoblastic leukemia: Pathophysiology and current therapy","volume":"58","author":"Imai","year":"2017","journal-title":"Rinsho Ketsueki"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","article-title":"Treatment of acute lymphoblastic leukemia\u201430 years\u2019 experience at St. Jude Children\u2019s Research Hospital","volume":"329","author":"Rivera","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/CCI.20.00144","article-title":"Aligning HER data for pediatric leukemia with standard protocol therapy","volume":"5","author":"Wood","year":"2021","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"28371","DOI":"10.1002\/pbc.28371","article-title":"Acute lymphoblastic leukemia","volume":"68","author":"Chang","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/pbc.24420","article-title":"COG Acute Lymphoblastic Leukemia Committee. Children\u2019s Oncology Group\u2019s 2013 blueprint for research: Acute lymphoblastic leukemia","volume":"60","author":"Hunger","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform Approach to Risk Classification and Treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_33","first-page":"94","article-title":"Comparison of treatment results in children with acute lymphoblastic leukemia treated in 1994-2001 and 2002-2007","volume":"62","author":"Derwich","year":"2012","journal-title":"J. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Malczewska, M., Ko\u015bmider, K., Bednarz, K., Ostapi\u0144ska, K., Lejman, M., and Zawitkowska, J. (2022). Recent advances in treatment options for childhood acute lymphoblastic leukemia. Cancers, 14.","DOI":"10.3390\/cancers14082021"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2021.03.034","article-title":"Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: Combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials","volume":"151","author":"Eckert","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JCO.2013.48.6522","article-title":"Intensive chemotherapy for childhood acute lymphoblastic leukemia: Results of the randomized intercontinental trial ALL IC-BFM 2002","volume":"32","author":"Stary","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajh.25619","article-title":"Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial","volume":"94","author":"Kowalczyk","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood.V87.12.4979.bloodjournal87124979","article-title":"Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children\u2019s Cancer Group","volume":"87","author":"Woods","year":"1996","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Childhood ALL Collaborative Group (1996). Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukemia: Overview of 42 trials involving 12000 randomised children. Lancet, 347, 1783\u20131788.","DOI":"10.1016\/S0140-6736(96)91615-3"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ejo\/19.2.151","article-title":"Long-term dental development in children after treatment for malignant disease","volume":"19","author":"Forsberg","year":"1997","journal-title":"Eur. J. Orthod."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/014107688708000405","article-title":"Effects of cytotoxic chemotherapy on dental development","volume":"80","author":"Macleod","year":"1987","journal-title":"J. R. Soc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stolze, J., Vlaanderen, K.C.E., Holtbach, F.C.E.D., Teepen, J.C., Kremer, L.C.M., Loonen, J.J., van Dulmen-den Broeder, E., van den Heuvel-Eibrink, M.M., Helena, J.H., and van der Pal, H.J.H. (2021). Long-term effects of childhood cancer treatment on dentition and oral health: A dentist survey study from the DCCSS LATER 2 Study. Cancers, 13.","DOI":"10.3390\/cancers13215264"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1002\/cncr.24670","article-title":"Impact of radiation and chemotherapy on risk of dental abnormalities: A report from the Childhood Cancer Survivor Study","volume":"115","author":"Kaste","year":"2009","journal-title":"Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cncr.25704","article-title":"Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy","volume":"117","author":"Hsieh","year":"2011","journal-title":"Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/pbc.22108","article-title":"Oral health and dental anomalies in patients treated for leukemia in childhood and adolescence","volume":"53","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1703330","article-title":"Long-term adverse effects on dentition in children with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation","volume":"29","author":"Alaluusua","year":"2002","journal-title":"Bone Marrow Transpl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-263X.1995.tb00301.x","article-title":"Dental caries experience of children in remission from acute lymphoblastic leukemia in relation to the duration of treatment and the period of time in remission","volume":"5","author":"Kinirons","year":"1995","journal-title":"Int. J. Paediatr. Dent."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5114\/jos.2019.87522","article-title":"A critical look at prevalence assessment of dental abnormalities after chemotherapy. Clinical research","volume":"72","year":"2019","journal-title":"J. Stomatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/22\/5420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:23:16Z","timestamp":1760131396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/22\/5420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":48,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["cancers15225420"],"URL":"https:\/\/doi.org\/10.3390\/cancers15225420","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]}}}